CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 113 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764,050 | -71.9% | 35,000 | -68.6% | 0.00% | -75.0% |
| Q1 2023 | $2,717,046 | -78.6% | 111,400 | -72.4% | 0.01% | -81.4% |
| Q4 2022 | $12,714,689 | -58.5% | 403,129 | -62.8% | 0.04% | -64.8% |
| Q3 2022 | $30,641,000 | +472.8% | 1,084,240 | +436.0% | 0.12% | +430.4% |
| Q2 2022 | $5,349,000 | +28.2% | 202,300 | +43.1% | 0.02% | +27.8% |
| Q3 2021 | $4,171,000 | -55.8% | 141,400 | -61.6% | 0.02% | -57.1% |
| Q2 2021 | $9,442,000 | +131.8% | 368,550 | +24.2% | 0.04% | +121.1% |
| Q1 2021 | $4,074,000 | +104.7% | 296,700 | +147.2% | 0.02% | +90.0% |
| Q4 2020 | $1,990,000 | – | 120,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,965,701,000 | 23.51% |
| Affinity Asset Advisors, LLC | 225,000 | $7,295,000 | 2.65% |
| Perceptive Advisors | 10,173,454 | $329,822,000 | 2.54% |
| Artal Group S.A. | 1,500,000 | $48,630,000 | 1.32% |
| Rock Springs Capital Management LP | 1,648,435 | $53,442,000 | 1.24% |
| RTW INVESTMENTS, LP | 666,666 | $21,613,000 | 0.32% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 8,900 | $289,000 | 0.28% |
| EAM Investors, LLC | 39,907 | $1,294,000 | 0.21% |
| FEDERATED HERMES, INC. | 3,113,333 | $100,934,000 | 0.19% |
| Alkeon Capital Management | 1,909,035 | $61,891,000 | 0.12% |